Clinical Observation of Azithromycin Combined with Doxazosin and Qianlieanshuan in the Treatment of NIH Ⅲ Prostatitis
柳建明,姜辉,洪锴,赵连明,唐文豪,马潞林
DOI: https://doi.org/10.3969/j.issn.1009-8291.2010.03.012
2010-01-01
Abstract:Objective To study the efficacy of Azithromycin combined with Doxazosin and Qianlieanshuan in the treatment of National Institute of Health(NIH) chronic nonbacterial prostatitis(CNP).Methods 180 CNP patients were equally randomized into an experimental group and a control group.The former were treated by oral Azithromycin 0.25g twice a day,oral Doxazosin 4mg and anal plug Qianlieanshuan 4g every night for 4 weeks.The latter were given oral Azithromycin 0.5g once a day for 4 weeks.All patients were evaluated by NIH-CPSI scores,and EPS test after 4 weeks. Results The overall scores of the experimental group pre-and post-treatment were 23.85±3.56 and 12.20±2.06 for NIH-CPSI,12.78±1.54 and 6.35±1.08 for pain,5.36±1.42 and 2.33±0.55 for urinary symptoms,7.46±1.52 and 4.36±0.68 for the quality of life,18.45±2.63 and 7.82±1.26 /HP for leukocyte counts in EPS.These of the contral group were 23.63±2.76 and 13±2.35,12.75±1.60 and 7.12±1.79,5.48±1.36 and 2.47±0.64,7.38±1.49 and 4.81±0.76,18.47±2.65 and 10.06±1.15 /HP.There were significant differences not only in the scores of post-treatment between the two groups,but also in the scores between pre-and post-treatment for each group(P0.01).Conclusion Azithromycin combined with Doxazosin and Qianlieanshuan can effectively relieve pain and urinary symptoms,improve the quality of life,reduce leukocyte counts in EPS of CNP patients and achieve better efficacy.
What problem does this paper attempt to address?